People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FirstString Research, Inc. | — | Pharmaceuticals | Series B | $45.0M | $665.3M | 2019 |
James R. McNab at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James R. McNab on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James R. McNab, Jr. | 1 | 3 |
| Tina Grant Nova | 1 | 1 |
| Gautam S. Ghatnekar | 1 | 1 |
| David Grant Leffell | 1 | 1 |
| Neal Grant McConnell | 1 | 1 |
| D. Grant Carwile | 1 | 1 |
| Tony Grant Bartsh | 1 | 1 |
| Elliot S. Favus | 1 | 1 |
| Steven W. Speer | 1 | 1 |
| Tony W. Bartsh | 1 | 1 |
| Elliot W. Favus | 1 | 1 |
| Grant R. Carwile | 1 | 1 |
| Stephen W. Speer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.